Case and Research Letter
Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis
Estudio de eficacia y supervivencia de apremilast en 65 pacientes con psoriasis y artritis psoriásica
P. Garbayo Salmons
, V. Expósito Serrano, J. Romaní de Gabriel, M. Ribera Pibernat
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario Parc Taulí de Sabadell, Sabadell, Barcelona, Spain
Leído
5148
Vecesse ha leído el artículo
1529
Total PDF
3619
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 75 | 9 | 84 |
| 2025 5 | 235 | 45 | 280 |
| 2025 4 | 186 | 33 | 219 |
| 2025 3 | 185 | 24 | 209 |
| 2025 2 | 187 | 46 | 233 |
| 2025 1 | 119 | 33 | 152 |
| 2024 12 | 104 | 52 | 156 |
| 2024 11 | 142 | 61 | 203 |
| 2024 10 | 92 | 47 | 139 |
| 2024 9 | 128 | 29 | 157 |
| 2024 8 | 124 | 50 | 174 |
| 2024 7 | 78 | 47 | 125 |
| 2024 6 | 97 | 53 | 150 |
| 2024 5 | 81 | 41 | 122 |
| 2024 4 | 71 | 31 | 102 |
| 2024 3 | 95 | 54 | 149 |
| 2024 2 | 85 | 38 | 123 |
| 2024 1 | 79 | 37 | 116 |
| 2023 12 | 61 | 19 | 80 |
| 2023 11 | 94 | 33 | 127 |
| 2023 10 | 63 | 31 | 94 |
| 2023 9 | 63 | 37 | 100 |
| 2023 8 | 53 | 15 | 68 |
| 2023 7 | 66 | 46 | 112 |
| 2023 6 | 49 | 21 | 70 |
| 2023 5 | 52 | 27 | 79 |
| 2023 4 | 50 | 20 | 70 |
| 2023 3 | 84 | 32 | 116 |
| 2023 2 | 48 | 23 | 71 |
| 2022 1 | 57 | 50 | 107 |
| 2022 12 | 84 | 46 | 130 |
| 2022 11 | 68 | 42 | 110 |
| 2022 10 | 82 | 38 | 120 |
| 2022 9 | 80 | 53 | 133 |
| 2022 8 | 93 | 48 | 141 |
| 2022 7 | 87 | 44 | 131 |
| 2022 6 | 119 | 53 | 172 |
| 2022 5 | 79 | 72 | 151 |
| 2022 4 | 24 | 49 | 73 |
Mostrar todo
